MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
162 hedge funds and large institutions have $873M invested in Momenta Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 49 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $962M → $873M (-$89.3M)
Holders
162
Holding in Top 10
1
Calls
$1.54M
Puts
$329K
Top Buyers
| 1 | +$117M | |
| 2 | +$12.3M | |
| 3 | +$7.71M | |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$5.75M |
| 5 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$5.61M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$15M | |
| 3 | -$11.3M | |
| 4 |
SC
Samlyn Capital
New York
|
-$3.97M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$2.92M |